Association of ACE I/D Polymorphism with Risk of Diabetes in Cardiovascular Disease Patients

Abstract

Angiotensin converting enzyme (ACE), as part of renin angiotensin aldosterone system, is involved in blood pressure regulation and control several physiological functions. Insertion/Deletion (I/D) polymorphism of ACE has pronounced effects on development of metabolic diseases like diabetes, cardiovascular diseases (CVDs) and hypertension. However, association of I/D polymorphism with risk of diabetes in CVD patients is not known. The aim of present study was to check the association of ACE I/D polymorphism with risk of diabetes in subjects with CVD. For this, 531 subjects were sampled and divided into 3 groups; G1-H (healthy controls, n=117), G2-CN (cardiac patients without diabetes, n=271) and G3-CD (cardiac patients with diabetes, n=143). Genotyping of ACE I/D polymorphism was done by polymerase chain reaction. Allelic and genotypic frequencies were in Hardy Weinberg Equilibrium (χ2=0.11, p>0.05) and revealed high prevalence of I allele (55%) among all groups. However, II genotype was more common (37%) in G3-CD group. Level of glucose was also higher in subjects with II genotype than DD genotype (12.6±6.3 mmol/L vs. 9.7±5.1 mmol/L). Logistic regression analysis revealed that ACE II genotype increase the risk of diabetes in CVD patients by ~2 times [OR=1.94, CI: 1.24–3.01, p=0.03]; however, this association did not reach the significance level when adjusted for age and gender. In conclusion, ACE I/D polymorphism influence the risk of diabetes in CVD patients and ACE II increases this risk by ~2 fold.

Key words

cardiovascular diseases - diabetes - ACE - I/D polymorphism - II genotype

• References

• 1 Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A. et al. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?. World J Diabetes 2014; 5: 444. doi:10.4239/wjd.v5.i4.444
• 2 Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol 2014; 6: a009191. doi:10.1101/cshperspect.a009191
• 3 Sharma JN, Narayanan P. The Kallikrein–Kinin Pathways in hypertension and diabetes. Prog Drug Res 2014; 69: 15-36
• 4 Ferrario CM, Strawn WB. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 2006; 98: 121-128
• 5 Hsueh WA, Wyne K. Renin-angiotensin-aldosterone system in diabetes and hypertension. J Clin Hypertens 2011; 13: 224-237
• 6 Hayashi T, Takai S, Yamashita C. Impact of the renin-angiotensin-aldosterone-system on cardiovascular and renal complications in diabetes mellitus. Curr Vasc Pharmacol 2010; 8: 189-197
• 7 Hussain M, Awan FR. Hypertension regulating angiotensin peptides in the pathobiology of cardiovascular disease. Clin Exp Hypertens 2018; 40: 344-352. doi:10.1080/10641963.2017.1377218
• 8 Chu KY, Leung PS. Angiotensin II in type 2 diabetes mellitus. Curr Protein Pept Sci 2009; 10: 75-84
• 9 Hubert C, Houot A-M, Corvol P. et al. Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem 1991; 266: 15377-15383
• 10 He Q, Fan C, Yu M. et al. Associations of ACE gene insertion/deletion polymorphism, ACE activity, and ACE mRNA expression with hypertension in a Chinese population. PLoS One 2013; 8: e75870
• 11 Baruah S, Chaliha MS, Borah PK. et al. Insertion/Insertion genotype of angiotensin i-converting-enzyme gene predicts risk of myocardial infarction in north east india. Biochem Genet 2016; 54: 134-146. doi:10.1007/s10528-015-9706-9
• 12 Al-Serri A, Ismael FG, Al-Bustan SA. et al. Association of the insertion allele of the common ACE gene polymorphism with type 2 diabetes mellitus among Kuwaiti cardiovascular disease patients. J Renin Angiotensin Aldosterone Syst 2015; 16: 910-916. doi:10.1177/1470320315610255
• 13 Hussain M, Awan FR, Gujjar A. et al. A case control association study of ACE gene polymorphism (I/D) with hypertension in Punjabi population from Faisalabad, Pakistan. Clin Exp Hypertens 2018; 40: 186-191 doi:10.1080/10641963.2017.1356842
• 14 Baroudi T, Bouhaha R, Moran-Moguel C. et al. Association of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene with type 2 diabetes in two ethnic groups of Jerba Island in Tunisia. J Renin Angiotensin Aldosterone Syst 2009; 10: 35-40. doi:10.1177/1470320309102314
• 15 Ergen HA, Hatemi H, Agachan B. et al. Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Exp Mol Med 2004; 36: 345-350. doi:10.1038/emm.2004.45
• 16 Faul F, Erdfelder E, Buchner A. et al. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods 2009; 41: 1149-1160. doi:10.3758/brm.41.4.1149
• 17 Whelton PK, Carey RM, Aronow WS. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines 2018; 71: e127-e248. doi:10.1016/j.jacc.2017.11.006
• 18 ADA. 2. Classification and diagnosis of diabetes. Diabetes care 2015; 38: 8-16. doi:10.2337/dc15-S005
• 19 Islam M, Awan FR, Baig SM. Development of ARMS-PCR assay for genotyping of Pro12Ala SNP of PPARG gene: A cost effective way for case–control studies of type 2 diabetes in developing countries. Molecular biology reports 2014; 41: 5585-5591
• 20 Rigat B, Hubert C, Corvol P. et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1)(dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20: 1433
• 21 Wang Y, Peng W, Zhang X. et al. The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan. J Renin Angiotensin Aldosterone Syst 2016; 17. doi:10.1177/1470320316666749
• 22 Alsafar H, Hassoun A, Almazrouei S. et al. Association of angiotensin converting enzyme insertion-deletion polymorphism with hypertension in emiratis with type 2 diabetes mellitus and its interaction with obesity status. Dis Markers 2015; 2015: 536041. doi:10.1155/2015/536041
• 23 Ramachandran V, Ismail P, Stanslas J. et al. Association of insertion/deletion polymorphism of angiotensin-converting enzyme gene with essential hypertension and type 2 diabetes mellitus in Malaysian subjects. J Renin Angiotensin Aldosterone Syst 2008; 9: 208-214. doi:10.1177/1470320308097499
• 24 Zhou D, Ruiter R, Zhang J. et al. Angiotensin-converting enzyme I/D polymorphism is not associated with type 2 diabetes in a Chinese population. J Renin Angiotensin Aldosterone Syst 2012; 13: 372-378. doi:10.1177/1470320311435535
• 25 Al-Saikhan FI, Abd-Elaziz MA, Ashour RH. Association between risk of type 2 diabetes mellitus and angiotensin-converting enzyme insertion/deletion gene polymorphisms in a Saudi Arabian population. Biomed Rep 2017; 7: 56-60 doi:10.3892/br.2017.920
• 26 Singh PP, Naz I, Gilmour A. et al. Association of APOE (Hha1) and ACE (I/D) gene polymorphisms with type 2 diabetes mellitus in North West India. Diabetes Res Clin Pract 2006; 74: 95-102. doi:10.1016/j.diabres.2006.03.013
• 27 Singh M, Singh A, Singh S. et al. Angiotensin-converting enzyme gene I/D polymorphism increases the susceptibility to hypertension and additive diseases: A study on North Indian patients. Clin Exp Hypertens 2016; 38: 305-311. doi:10.3109/10641963.2015.1107085
• 28 Folli F, Saad M, Velloso L. et al. Crosstalk between insulin and angiotensin II signalling systems. Exp Clin Endocrinol Diabetes 1999; 107: 133-139
• 29 Buchanan TA, Thawani H, Kades W. et al. Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism. J Clin Invest 1993; 92: 720-726. doi:10.1172/JCI116642
• 30 Morris AD, Petrie JR, Ueda S. et al. Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM: Dissociation of metabolic and blood pressure effects. Diabetes 1994; 43: 1445-1449
• 31 Fliser D, Arnold U, Kohl B. et al. Angiotensin II enhances insulin sensitivity in healthy volunteers under euglycemic conditions. J Hypertens 1993; 11: 983-988
• 32 Takezako T, Saku K, Zhang B. et al. Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with angina pectoris. Am J Hypertens 1999; 12: 291-297. doi:10.1016/S0895-7061(98)00263-5
• 33 Ryan AS, Nicklas BJ, Berman DM. et al. The insertion/deletion polymorphism of the ACE gene is related to insulin sensitivity in overweight women. Diabetes Care 2001; 24: 1646-1652. doi:10.2337/diacare.24.9.1646
• 34 Panahloo A, Andrès C, Mohamed-Ali V. et al. The insertion allele of the ACE gene I/D polymorphism: a candidate gene for insulin resistance?. Circulation 1995; 92: 3390-3393
• 35 Alvarez-Aguilar C, Enríquez-Ramírez ML, Figueroa-Nuñez B. et al. Association between angiotensin-1 converting enzyme gene polymorphism and the metabolic syndrome in a Mexican population. Exp Mol Med 2007; 39: 327
• 36 Zhou M-S, Schulman IH, Zeng Q. Link between the renin–angiotensin system and insulin resistance: Implications for cardiovascular disease. Vasc Med 2012; 17: 330-341
• 37 Olivares-Reyes JA, Arellano-Plancarte A, Castillo-Hernandez JR. Angiotensin II and the development of insulin resistance: implications for diabetes. Mol Cell Endocrinol 2009; 302: 128-139
• 38 Underwood PC, Adler GK. The renin angiotensin aldosterone system and insulin resistance in humans. Curr Hypertens Rep 2013; 15: 59-70
• 39 Williams SF, Nicholas SB, Vaziri ND. et al. African Americans, hypertension and the renin angiotensin system. World J Cardiol 2014; 6: 878
• 40 Smith LM, Yao-Borengasser A, Starks T. et al. Insulin resistance in African-American and Caucasian women: Differences in lipotoxicity, adipokines, and gene expression in adipose tissue and muscle. J Clin Endocrinol Metab 2010; 95: 4441-4448
• 41 Rivière G, Lienhard D, Andrieu T. et al. Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation. Epigenetics 2011; 6: 478-489
• 42 Rangel M, dos Santos JC, Ortiz PHL. et al. Modification of epigenetic patterns in low birth weight children: importance of hypomethylation of the ACE gene promoter. PloS one 2014; 9: e106138
• 43 Alegría-Torres JA, Baccarelli A, Bollati V. Epigenetics and lifestyle. Epigenomics 2011; 3: 267-277